BioSpace News Archive

Press Release Summary: Northside Hospital Gwinnett installs the first STAAT ModTM units in the Atlanta metro area to provide inpatient care capacity for COVID-19 patients and a growing population.

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced the company has joined the Decentralized Trials & Research Alliance (DTRA), a new alliance of 50 life sciences and healthcare organizations focused on expanding access to clinical trials by advancing policies, research practices and digital-heal

At the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, a series of late-breaking sessions will delve into the newest research on the rapidly evolving COVID-19 pandemic.

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. This is

As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Zynx Health® today announced that it has published a new, publicly available review of vaccine administration guidelines specific to COVID-19 vaccines, including Pfizer/BioNTech BNT162b2, the COVID-19 vaccine co-developed by Pfizer and BioNTech, following its emergency use approval by the U.S. Food and Drug Administration (FDA).

HeartFlow, Inc., a leader in revolutionizing precision heartcare, announced that a new cost-effectiveness analysis found a diagnostic pathway which utilizes coronary computed tomography angiography with the HeartFlow FFRct Analysis to be “dominant” as compared to stress testing for assessing patients with coronary artery disease, the leading cause of death.

Over two million babies, children, and adults in the United States are living with congenital heart disease—a range of birth defects affecting the heart’s structure or function.

Quantum Health, the leading consumer healthcare navigation and care coordination company, is now integrating vaccine care planning into its core service offering

Approval based on data from the randomized, double-blind ENSEMBLE PLUS study, showing consistent safety to the conventional Ocrevus dosing regimen – – Shorter infusion time will further improve the twice-yearly treatment experience for Ocrevus, the only B-cell therapy for relapsing and primary progressive MS with a twice-yearly dosing schedule – SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Genentech, a member of the Roche Group (SIX: R